These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 14489620)

  • 1. The effect of dextrothyroxine on the disappearance from the blood of C14-labeled cholesterol. A preliminary report.
    RABINOWITZ JL; RODMAN T; SMOLINSKY TL
    Angiology; 1962 Feb; 13():81-4. PubMed ID: 14489620
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of dextrothyroxine on the disappearance from the blood of C14-labeled cholesterol; a preliminary report.
    RABINOWITZ JL; RODMAN T; SMOLINSKY TL
    Angiology; 1962 Jul; 13():319-23. PubMed ID: 14489621
    [No Abstract]   [Full Text] [Related]  

  • 3. Reduction of serum cholesterol by sodium dextrothyroxine in euthyroid subjects.
    SCHNEEBERG NG; HERMAN E; MENDUKE H; ALTSCHULER NK
    Ann Intern Med; 1962 Feb; 56():265-75. PubMed ID: 13908890
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of dextrothyroxin and androsterone on serum cholesterol and the coagulation factors in atherosclerotics].
    DUFAULT C; TREMBLAY G; NOWACZYNSKI W; GENEST J
    Med Hyg (Geneve); 1962 Apr; 20():307-11. PubMed ID: 13888220
    [No Abstract]   [Full Text] [Related]  

  • 5. Objective effects of dextrothyroxine therapy.
    OWEN WR; OWENS JC; NEELY WB
    Angiology; 1962 Feb; 13():75-8. PubMed ID: 14482905
    [No Abstract]   [Full Text] [Related]  

  • 6. One year of sodium dextrothyroxine therapy for hypercholesterolemia.
    COHEN BM
    Angiology; 1962 Feb; 13():69-74. PubMed ID: 13880229
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of hypercholesterolemia in human subjects with sodium D-thyroxine.
    FIFER WR
    Dis Chest; 1962 Jul; 42():21-8. PubMed ID: 13892797
    [No Abstract]   [Full Text] [Related]  

  • 8. Observations on sodium D-thyroxine as a hypocholesteremic agent in persons with hypercholesteremia with and without ischemic heart disease.
    WINTERS WL; SOLOFF LA
    Am J Med Sci; 1962 Apr; 243():458-69. PubMed ID: 14007620
    [No Abstract]   [Full Text] [Related]  

  • 9. Some observations on the relationships between atherosclerosis, hyperlipemia, and D-thyroxine.
    DAVIS OF; BECK C; BERGAL M; SLOAN N; LEVINE AJ
    Am Heart J; 1962 Jul; 64():7-12. PubMed ID: 13883947
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of dextrothyroxine on serum cholesterol.
    MORGAN R; GRACE WJ
    Curr Ther Res Clin Exp; 1962 Jun; 4():297-300. PubMed ID: 14475971
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of sodium dextrothyroxine on serum cholesterol in man.
    OWEN WR; NEELY WB; OWENS JC
    JAMA; 1961 Dec; 178():1036-8. PubMed ID: 14482904
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of sodium dextrothyroxine in patients receiving anticoagulants.
    OWENS JC; NEELY WB; OWEN WR
    Clin Med (Northfield); 1962 Oct; 69():2283-4. PubMed ID: 15445906
    [No Abstract]   [Full Text] [Related]  

  • 13. Cholesterol reduction in patients with arteriosclerosis.
    BERNSTEIN A; SIMON F
    Angiology; 1962 Feb; 13():79-80. PubMed ID: 13868252
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of D-thyroxine on serum cholesterol.
    GREENE R; PEARCE JF; RIDEOUT DF
    Br Med J; 1961 Jun; 1(5239):1572-4. PubMed ID: 13708306
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of dextrothyroxine on metabolism of C-14-labeled cholesterol and tripalmitin.
    RABINOWITZ JL; RODMAN T; MYERSON RM
    JAMA; 1963 Mar; 183():758-60. PubMed ID: 13972877
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of D-thyroxine on thyrotoxicosis and on the associated exophthalmos.
    ALEXANDER WD; KOUTRAS DA; BUCHANAN WW; CROOKS J
    Br Med J; 1961 Apr; 1(5234):1194-5. PubMed ID: 13682374
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of sodium dextrothyroxine on serum cholesterol and mortality rates in cardiac patients.
    Bernstein A; Simon F; Schmitz TH; Warner WL
    Angiology; 1973 Apr; 24(4):205-11. PubMed ID: 4699516
    [No Abstract]   [Full Text] [Related]  

  • 18. [ARTERIOSCLEROSIS AND HYPERCHOLESTEREMIA TREATED WITH DEXTROTHYROXIN].
    BASABE H; GENTILE FA; BLANDA H
    Sem Med; 1963 Jun; 122():1375-7. PubMed ID: 14073883
    [No Abstract]   [Full Text] [Related]  

  • 19. [ACTION OF DEXTRO-THYROXIN IN TREATMENT OF DYSLIPEMIAS OF ATHEROSCLEROSIS].
    SIMONIN R; FRUCTUS X; GEROLAMI AUDRIC D
    Gaz Med Fr; 1964 Dec; 71():4310-7. PubMed ID: 14261773
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypolipoproteinemic effects of short-term sodium D-thyroxine therapy.
    SEARCY RL; CARLUCCI JS; CARROLL VP; BERGQUIST LM
    J Atheroscler Res; 1961; 1():247-50. PubMed ID: 13910200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.